GlycoVaxyn AG of Switzerland has announced that Stanley A Plotkin, developer of the rubella vaccine, is joining its supervisory board. Dr Plotkin is Emeritus Professor of the University of Pennsylvania and a consultant to many vaccine manufacturers. Until 1991, he was professor of pediatrics and microbiology at the University of Pennsylvania and professor of virology at the Wistar Institute. He was simultaneously director of infectious diseases and senior physician at the Children’s Hospital of Philadelphia. Dr Plotkin is co-developer of a vaccine against rotavirus and has worked extensively on the development and application of other vaccines, including polio, rabies, varicella, and cytomegalovirus. He has received numerous awards and in 2005 was elected to the Institute of Medicine of the National Academy of Sciences.
Based in Schlieren, Switzerland, GlycoVaxyn has developed a portfolio of novel conjugate vaccines against bacterial infections including hospital-acquired Staphylococcus aureus.
Copyright 2009 Evernow Publishing Ltd